306 Publications (Page 10 of 13)
2001
Assessment of dietary therapies in a canine model of Batten disease
Siakotos, Aristotle N⋅Siakotos, Aristotle N⋅Siakotos, Aristotle N⋅Hutchins, G D⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Farlow, M R⋅Farlow, Martin R⋅Farlow, Martin R⋅Katz, Martin L⋅Katz, Martin L and Katz, Martin L
European Journal of Paediatric Neurology, vol. 5, pp. 156, 2001. | Journal Article
 
Biochemical characterization of a neuroserpin variant associated with hereditary dementia.
Yazaki, M⋅Liepnieks, J J⋅Murrell, Jill R⋅Takao, M⋅Guenther, B⋅Piccardo, Pedro⋅Farlow, Martin R⋅Ghetti, Bernardino and Benson, Merrill D
The American journal of pathology, vol. 158, (no. 1), pp. 227-33, 2001/Jan. | Journal Article
 
Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer's Disease
Doody, Rachelle S⋅Dunn, J. K⋅Clark, Christopher M⋅Farlow, Martin R⋅Foster, Norman⋅Liao, T.⋅Gonzales, N.⋅Lai, Eugene C and Massman, Paul J
Dementia and Geriatric Cognitive Disorders, vol. 12, (no. 4), pp. 295-300, 2001. | Journal Article
 
Ectopic White Matter Neurons, a Developmental Abnormality That May Be Caused by the PSEN1 S169L Mutation in a Case of Familial AD with Myoclonus and Seizures
Takao, M.⋅Ghetti, Bernardino⋅Murrell, Jill R⋅Unverzagt, Frederick⋅Giaccone, G.⋅Tagliavini, F.⋅Bugiani, O.⋅Piccardo, Pedro⋅Hulette, Christine M⋅Crain, Barbara J⋅Farlow, Martin R and Heyman, Albert
Journal of Neuropathology & Experimental Neurology, vol. 60, (no. 12), pp. 1137-1152, 2001. | Journal Article
 
Ectopic White Matter Neurons, a Developmental Abnormality That May Be Caused by thePSEN1S169L Mutation in a Case of Familial AD with Myoclonus and Seizures
Takao, Masaki⋅Takao, Masaki⋅Takao, Masaki⋅Ghetti, Bernardino⋅Ghetti, Bernardino⋅Ghetti, Bernardino⋅Murrell, Jill R⋅Murrell, Jill R⋅Murrell, Jill R⋅Unverzagt, Frederick W⋅Unverzagt, Frederick W⋅Unverzagt, Frederick W⋅Giaccone, Giorgio⋅Giaccone, Giorgio⋅Giaccone, Giorgio⋅Tagliavini, Fabrizio⋅Tagliavini, Fabrizio⋅Tagliavini, Fabrizio⋅Bugiani, Orso⋅Bugiani, Orso⋅Bugiani, Orso⋅Piccardo, Pedro⋅Piccardo, Pedro⋅Piccardo, Pedro⋅Hulette, Christine M⋅Hulette, Christine M⋅Hulette, Christine M⋅Crain, Barbara J⋅Crain, Barbara J⋅Crain, Barbara J⋅Farlow, Martin R⋅Farlow, Martin R⋅Farlow, Martin R⋅Heyman, Albert⋅Heyman, Albert and Heyman, Albert
Journal of Neuropathology & Experimental Neurology, vol. 60, (no. 12), pp. 1152, 2001-12-00. | Journal Article
 
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons
Lin, Suizhen⋅Lin, Suizhen⋅Zhang, Yuqin⋅Zhang, Yuqin⋅Dodel, Richard⋅Dodel, Richard⋅Farlow, Martin R⋅Farlow, Martin R⋅Paul, Steven M⋅Paul, Steven M⋅Du, Yansheng and Du, Yansheng
Neuroscience Letters, vol. 315, (no. 1), pp. 64, 2001. | Journal Article
 
New concepts in the drug therapy of Alzheimer’s disease
Farlow, Martin R and Hake, Ann Marie
Expert Opinion on Pharmacotherapy, vol. 2, (no. 12), pp. 1983, 2001-12-00. | Journal Article
 
Olfactory-Evoked Regional Cerebral Blood Flow in Alzheimer's Disease
Kareken, David A⋅Kareken, David A⋅Kareken, David A⋅Doty, Richard L⋅Doty, Richard L⋅Doty, Richard L⋅Moberg, Paul J⋅Moberg, Paul J⋅Moberg, Paul J⋅Mosnik, D⋅Mosnik, Diane⋅Mosnik, Diane⋅Chen, Shen Hsing⋅Chen, S H⋅Chen, Shen Hsing⋅Farlow, M R⋅Farlow, Martin R⋅Farlow, Martin R⋅Hutchins, Gary D⋅Hutchins, Gary D and Hutchins, G D
Neuropsychology, vol. 15, (no. 1), pp. 29, 20010100. | Journal Article
 
Panel discussion:recommendations for prescribers
Morris, John C⋅Farlow, Martin R⋅Ferris, Steven H⋅Kurz, Alexander F⋅Maelicke, Alfred⋅Rasmusen, Lee⋅Wilkinson, David and Yan, Bing
Clinical Therapeutics, vol. 23, pp. A39, 2001. | Journal Article
 
Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine.
Farlow, Martin R
Clinical therapeutics. , vol. 23 Suppl A, pp. A13-24, 2001. | Journal Article
 
Pharmacokinetic profiles of current therapiesfor Alzheimer's disease: implications for switching to galantamine
Farlow, Martin R
Clinical Therapeutics, vol. 23, pp. A24, 2001. | Journal Article
 
Prion Proteins with Different Conformations Accumulate in Gerstmann-Sträussler-Scheinker Disease Caused by A117V and F198S Mutations
Piccardo, Pedro⋅Piccardo, Pedro⋅Piccardo, Pedro⋅Piccardo, Pedro⋅Liepnieks, J J⋅Liepnieks, Juris J⋅Liepnieks, Juris J⋅Liepnieks, Juris J⋅William, A⋅William, Albert⋅William, Albert⋅William, Albert⋅Dlouhy, Stephen R⋅Dlouhy, Stephen R⋅Dlouhy, S R⋅Dlouhy, Stephen R⋅Farlow, Martin R⋅Farlow, M R⋅Farlow, Martin R⋅Farlow, Martin R⋅Young, Katherine⋅Young, K⋅Young, Katherine⋅Young, Katherine⋅Nochlin, David⋅Nochlin, David⋅Nochlin, David⋅Nochlin, David⋅Bird, Thomas D⋅Bird, Thomas D⋅Bird, Thomas D⋅Bird, T D⋅Nixon, Randal R⋅Nixon, Randal R⋅Nixon, Randal R⋅Nixon, R R⋅Ball, Melvyn J⋅Ball, M J⋅Ball, Melvyn J⋅Ball, Melvyn J⋅DeCarli, Charles⋅DeCarli, C⋅DeCarli, Charles⋅DeCarli, Charles⋅Bugiani, O⋅Bugiani, Orso⋅Bugiani, Orso⋅Bugiani, Orso⋅Tagliavini, Fabrizio⋅Tagliavini, Fabrizio⋅Tagliavini, F⋅Tagliavini, Fabrizio⋅Benson, Merrill D⋅Benson, Merrill D⋅Benson, Merrill D⋅Benson, M D⋅Ghetti, Bernardino⋅Ghetti, B⋅Ghetti, Bernardino and Ghetti, Bernardino
The American Journal of Pathology, vol. 158, (no. 6), pp. 2207, 2001. | Journal Article
 
Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.
Du, Yansheng⋅Dodel, R⋅Hampel, H⋅Buerger, K⋅Lin, S⋅Eastwood, B⋅Bales, K⋅Gao, F⋅Moeller, H J⋅Oertel, Wolfgang H⋅Farlow, Martin R and Paul, S
Neurology. , vol. 57, (no. 5), pp. 801-5, 2001/Sep/11. | Journal Article
 
Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.
Farlow, Martin R⋅Hake, A⋅Messina, J⋅Hartman, R⋅Veach, J and Anand, R
Archives of neurology. , vol. 58, (no. 3), pp. 417-22, 2001/Mar. | Journal Article
 
Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.
Morris, John C⋅Farlow, Martin R⋅Ferris, Steven H⋅Kurz, A F⋅Maelicke, A⋅Rasmusen, L⋅Wilkinson, D and Yan, B
Clinical therapeutics, vol. 23 Suppl A, pp. A31-9, 2001. | Journal Article
2000
A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer's Disease
Farlow, Martin R⋅Anand, Ravi⋅Messina Jr, John⋅Hartman, Richard and Veach, Jeffrey
European Neurology, vol. 44, (no. 4), pp. 236-241, 2000. | Journal Article
 
A 52-week study of the efficacy of rivastigmine in patient with mild to moderatley severe Alzheimer's disease
Farlow, Martin R⋅Anand, Ravi⋅Messina, John⋅Hartman, Richard and Veach, Jeffrey
European Neurology, vol. 44, (no. 4), pp. 236-41, Nov 2000. | Journal Article
 
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
Aisen, Paul S⋅Davis, K L⋅Berg, J D⋅Schafer, K⋅Campbell, K⋅Thomas, Ronald G⋅Weiner, M F⋅Farlow, Martin R⋅Sano, M⋅Grundman, M and Thal, L J
Neurology, vol. 54, (no. 3), pp. 588-93, 2000/Feb/8. | Journal Article
 
Clinical characteristics in a family with early-onset Alzheimer disease caused by a mutation (V717L) in the APP gene
Hake, Ann M⋅Hake, Ann M⋅Hake, Ann M⋅Murrell, Jill R⋅Murrell, Jill R⋅Murrell, Jill R⋅Unverzagt, Frederick W⋅Unverzagt, Frederick W⋅Unverzagt, Frederick W⋅Ghetti, Bernardino⋅Ghetti, Bernardino⋅Ghetti, Bernardino⋅Farlow, Martin R⋅Farlow, Martin R and Farlow, Martin R
Neurobiology of Aging, vol. 21, pp. 59, 2000. | Journal Article
 
early-onset Alzheimer disease caused by a new mutation (B717L) in the amyloid precursor protein gene
Murrell, Jill R⋅Hake, Ann M⋅Quaid, Kimberly A⋅Farlow, Martin R and Ghetti, Bernardino
Archives of Neurology, vol. 57, (no. 6), pp. 885-7, Jun 2000. | Journal Article
 
Early-Onset Alzheimer Disease Caused by a New Mutation (V717L) in the Amyloid Precursor Protein Gene
Murrell, Jill R⋅Murrell, Jill R⋅Hake, Ann M⋅Hake, A M⋅Quaid, Kimberly A⋅Quaid, K A⋅Farlow, M R⋅Farlow, Martin R⋅Ghetti, Bernardino and Ghetti, B
Archives of Neurology, vol. 57, (no. 6), pp. 887, 2000-06-01. | Journal Article
 
Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin.
Lahiri, Debomoy K⋅Ge, Y W and Farlow, Martin R
Annals of the New York Academy of Sciences. , vol. 903, pp. 387-93, 2000/Apr. | Journal Article
 
Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.
Henderson, Victor W⋅Paganini Hill, Annlia⋅Miller, Bruce L⋅Elble, R J⋅Reyes, P F⋅Shoupe, D⋅McCleary, C A⋅Klein, R A⋅Hake, A M and Farlow, Martin R
Neurology, vol. 54, (no. 2), pp. 295-301, 2000/Jan/25. | Journal Article
 
Hereditary lateral sclerosis and Alzheimer disease associated with mutation at codon 261 of the presenilin 1 (PS1) gene
Farlow, Martin R⋅Farlow, Martin R⋅Murrell, Jill R⋅Murrell, Jill R⋅Hulette, Christine M⋅Hulette, Christine M⋅Ghetti, Bernardino and Ghetti, Bernardino
Neurobiology of Aging, vol. 21, pp. 62, 2000. | Journal Article
 
Metrifonate Therapy in Alzheimer's Disease: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
Farlow, Martin R and Cyrus, PA
Dementia and Geriatric Cognitive Disorders, vol. 11, (no. 4), pp. 202-211, 2000. | Journal Article